Delivery Order SPE2DB24D2205-SPE2DB24FDSQQ

Award Date 4/15/24
Potential Completion Date 4/16/24
Potential Value $61K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,062.24, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This appears to be a one-time Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025. The IDC enables the DLA to efficiently...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,583.80 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 and running through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a $33,555.84 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
This federal contract award, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation and a leading global pharmaceutical distribution company. The contract, valued at $1,031.12, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This award is a child contract under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was previously...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,862.63, is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract is a Firm Fixed Price Delivery Order with a completion date of March 25, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The $15,731.94 delivery order is under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,299 firm-fixed-price delivery order to AmerisourceBergen Drug Corp's Corporate Office division for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a firm fixed price ceiling value of $15,555.94. The contract has an ultimate completion date of May 13, 2025. This appears to be a delivery order contract, without a set-aside designation, indicating open competition....
The U.S. Defense Logistics Agency (DLA) awarded a $25,778 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 4,564,306 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,682.02 delivery order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance through January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDSQQ
    Delivery Order

This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $60,849.55 firm-fixed-price delivery order is for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the DLA. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities globally. This contract award does not have a set-aside designation.

Generated 7/15/24, 6:49 PM